Midi Health vs NativeMed
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Midi Health
Best for women in menopause / perimenopause with commercial insurance who want GLP-1 prescribing as part of a broader hormone + metabolic care plan, not as a standalone weight-loss productStarting at $128/mo
NativeMed
Best for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribingStarting at $149/mo
Side-by-Side Comparison
| Feature | Midi Health | NativeMed |
|---|---|---|
| Overall Score | 7.0/10 | ✓7.1/10 |
| Starting Price | ✓$128/mo | $149/mo |
| Editorial Rating | 3.5 ★ /5 | ✓3.6 ★ /5 |
| Features | 4 features | 4 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Midi Health
Pros
- ✓Nationwide availability in all 50 states (verified on the public homepage)
- ✓Accepts commercial insurance — differentiator vs most cash-pay-only GLP-1 telehealth
- ✓Menopause + metabolic health specialty framing — useful for women in the demographic where GLP-1 efficacy and weight regulation overlap most
- ✓Compounded semaglutide pricing starts at $127.90/mo for uninsured patients per the public pricing/insurance page
Cons
- ✗Does NOT accept Medicare, Medicaid, or Medi-Cal — eliminates roughly 40% of the insured US adult population
- ✗GLP-1 prescribing is clinician-discretionary inside a broader menopause care plan, NOT a guaranteed offering at intake — readers signing up purely for GLP-1 access may not get it
- ✗Menopause-focused — not the right fit for men or younger women whose primary need is weight loss
NativeMed
Pros
- ✓LegitScript certified per the homepage footer (independently verifiable)
- ✓Promotional pricing publicly displayed: $149/mo semaglutide, $183/mo tirzepatide (sale from $299/$399 regular)
- ✓Async questionnaire workflow with synchronous visit triggered when state law requires it
Cons
- ✗Pharmacy partners are NOT publicly named — material gap for YMYL disclosure (described only as 'USA-based pharmacies' / 'accredited pharmacies')
- ✗States served list is not publicly enumerated
- ✗Pricing displayed as promotional sale price — readers should confirm whether the $149/$183 holds beyond the first month or escalates to the $299/$399 'regular' price
- ✗Trustpilot reviews displayed on homepage — we do NOT cite Trustpilot as a primary source per editorial policy
Our Verdict
NativeMed edges out Midi Health with a higher overall score of 7.1/10 and is particularly strong for buyers comfortable with sub-$200 promotional compounded GLP-1 pricing who can verify pharmacy partner identity directly with NativeMed support before subscribing. Midi Health remains a solid alternative, especially if you're looking for women in menopause / perimenopause with commercial insurance who want GLP-1 prescribing as part of a broader hormone + metabolic care plan, not as a standalone weight-loss product.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.